This neuronal activity can trigger the shedding of the synaptic protein Neuroligin-3 (NLGN3), which activates oncogenic signaling cascades and drives synaptic gene expression in glioma cells, potentially contributing to epileptic activity. Here, NLGN3 is linked to glioma.